Cerebrospinal fluid biomarkers, education, brain volume, and future cognition

Archives of Neurology

Volumn 68, Issue 9, 2011, Pages 1145-1152

  Roe, Catherine M ^a   Fagan, Anne M ^a   Grant, Elizabeth A ^a   Marcus, Daniel S ^a,b   Benzinger, Tammie L S ^a,b   Mintun, Mark A ^a,b,c   Holtzman, David M ^a   Morris, John C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AVID RADIOPHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; PHOSPHORYLATED TAU 181 PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; EDUCATIONAL STATUS; FEMALE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN DETERMINATION; SCORING SYSTEM;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOLOGICAL MARKERS; BRAIN; COGNITION; COGNITION DISORDERS; COGNITIVE RESERVE; COHORT STUDIES; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ORGAN SIZE; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TAU PROTEINS;

EID: 80052770038     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.192     Document Type: Article

References (38)

1. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA. 1994;271 (13):1004-1010. (Pubitemid 24099921)
2. Mori E, Hirono N, Yamashita H, et al. Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease.AmJ Psychiatry. 1997;154(1):18-24. (Pubitemid 27020187)
3. Borenstein Graves A, Mortimer JA, Bowen JD, et al. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology. 2001; 57(8):1453-1460. (Pubitemid 32995728)
4. Mortimer JA, Snowdon DA, Markesbery WR. Head circumference, education and risk of dementia: findings from the Nun Study. J Clin Exp Neuropsychol. 2003; 25(5):671-679. (Pubitemid 36808152)
5. Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord. 2006;20(2):112-117. (Pubitemid 44305911)
6. Katzman R, Terry R, DeTeresa R, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol. 1988;23(2):138-144. (Pubitemid 18081451)
7. Mortimer JA, Borenstein AR, Gosche KM, Snowdon DA. Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression. J Geriatr Psychiatry Neurol. 2005;18(4):218-223. (Pubitemid 41736387)
8. Valenzuela MJ. Brain reserve and the prevention of dementia. Curr Opin Psychiatry. 2008;21(3):296-302. (Pubitemid 351489352)
9. Bennett DA, Wilson RS, Schneider JA, et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology. 2003; 60(12):1909-1915. (Pubitemid 36736005)
10. Roe CM, Mintun MA, D'Angelo G, Xiong C, Grant EA, Morris JC. Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake. Arch Neurol. 2008;65(11):1467-1471.
11. Kemppainen NM, Aalto S, Karrasch M, et al. Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol. 2008;63(1):112-118. (Pubitemid 351240557)
12. Fagan AM, Holtzman DM. Cerebrospinal fluid biomarkers of Alzheimer's disease. Biomark Med. 2010;4(1):51-63.
13. 42 ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol. 2007;64(3):343-349.
14. Li G, Sokal I, Quinn JF, et al. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study. Neurology. 2007;69(7):631-639. (Pubitemid 47256004)
15. Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010;6(3):131-144.
16. Berg L, McKeel DW Jr, Miller JP, et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol. 1998;55 (3):326-335. (Pubitemid 28146197)
17. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566-572. (Pubitemid 12124384)
18. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412-2414. (Pubitemid 23346995)
19. Williams MM, Roe CM, Morris JC. Stability of the Clinical Dementia Rating, 1979-2007. Arch Neurol. 2009;66(6):773-777.
20. Burke WJ, Miller JP, Rubin EH, et al. Reliability of the Washington University Clinical Dementia Rating. Arch Neurol. 1988;45(1):31-32. (Pubitemid 18018582)
21. Morris JC, Ernesto C, Schaefer K, et al. Clinical Dementia Rating training and reliability in multicenter studies: the Alzheimer's Disease Cooperative Study experience. Neurology. 1997;48(6):1508-1510.
22. Storandt M, Grant EA, Miller JP, Morris JC. Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. Neurology. 2006; 67(3):467-473. (Pubitemid 44214972)
23. Petersen RC, Morris J. Clinical features. In: Peterson RC, ed. Mild Cognitive Impairment: Aging to Alzheimer's Disease. New York, NY: Oxford University Press; 2003:15-39.
24. Fagan AM, Mintun MA, Mach RH, et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann Neurol. 2006;59 (3):512-519. (Pubitemid 43358072)
25. Buckner RL, Head D, Parker J, et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlasbased head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage. 2004;23(2):724-738. (Pubitemid 39370623)
26. Styner M, Brechbühler C, Székely G, Gerig G. Parametric estimate of intensity inhomogeneities applied to MRI. IEEE Trans Med Imaging. 2000;19(3):153-165.
27. Smith SM, Zhang Y, Jenkinson M, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 2002;17 (1):479-489.
28. Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging. 2001;20(1):45-57. (Pubitemid 32293419)
29. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-198.
30. Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment. Am J Psychiatry. 1983;140(6):734-739. (Pubitemid 13094139)
31. Dreyfus DM, Roe CM, Morris JC. Autobiographical memory task in assessing dementia. Arch Neurol. 2010;67(7):862-866.
32. Fagan AM, Head D, Shah AR, et al. Decreased cerebrospinal fluid Aβ(42) correlates with brain atrophy in cognitively normal elderly. Ann Neurol. 2009;65(2):176-183.
33. Stern Y. Cognitive reserve. Neuropsychologia. 2009;47(10):2015-2028.
34. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Education modifies the association of amyloid but not tangles with cognitive function. Neurology. 2005;65(6):953-955. (Pubitemid 41362153)
35. Roe CM, Xiong C, Miller JP, Cairns NJ, Morris JC. Interaction of neuritic plaques and education predicts dementia. Alzheimer Dis Assoc Disord. 2008;22(2):188-193.
36. Roe CM, Fagan AM, Williams MM, et al. Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease. Neurology. 2011;76(6): 501-510.
37. Reisberg B. Global measures: utility in defining and measuring treatment response in dementia. Int Psychogeriatr. 2007;19(3):421-456. (Pubitemid 46707434)
38. Fotenos AF, Snyder AZ, Girton LE, Morris JC, Buckner RL. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD. Neurology. 2005;64(6):1032-1039. (Pubitemid 40388457)